Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT06729593
Eligibility Criteria:
Inclusion Criteria:
Refer to the master protocol (NCT04843761)
Exclusion Criteria:
Refer to the master protocol (NCT04843761)
Additional Exclusion Criteria:
* Prior receipt of any dose of remdesivir during the present illness
* GFR (glomerular filtration rate) \< 30 ml/min and not receiving dialysis
* ALT (alanine aminotransferase) or AST (aspartate aminotransferase) \> 10 times upper limit of normal
* Unwillingness to commit to avoid sex that may result in pregnancy for at least 7 days after completion of remdesivir vs. placebo
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06729593
Study Brief:
Protocol Section:
NCT06729593